Arginine

Arginine

SCHEMBL1278093

N=C(N)NCCC[C@H](N)C(=O)O.N=C(N)NCCC[C@H](N)C(=O)OC(=O)[C@@H](N)CCCCN.N[C@@H](COC(=O)[C@@H](N)CS)C(=O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.43
OTC P00480 1/20 0.35
GNAI3 P08754 1/20 0.34
GNAO1 P09471 1/20 0.34
GNAI1 P63096 1/20 0.34
CPB2 Q96IY4 3/20 0.34
NOS2 P35228 2/20 0.34
DDAH1 O94760 2/20 0.34
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
CYP1A2 P05177 1/20 0.32
GLA P06280 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
APEX1 P27695 1/20 0.32
CYP2C19 P33261 1/20 0.32
NPY4R P50391 2/20 0.31
NPY1R P25929 1/20 0.31
PTGS1 P23219 1/20 0.31
SLC7A11 Q9UPY5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6535302 0.93 GSR (0.45) GSROTCGNAI3GNAO1GNAI1
Arginine SCHEMBL6378532 0.85 NOS2 (0.40) OTCNOS2DDAH1NOS3NOS1
Glycine SCHEMBL7934640 0.85 GSR (0.38) GSROTCGNAI3GNAO1GNAI1
Arginine SCHEMBL28242594 0.85 GSR (0.56) GSROTCGNAI3GNAO1GNAI1
Arginine SCHEMBL28527646 0.85 GSR (0.56) GSROTCGNAI3GNAO1GNAI1
Lysine SCHEMBL5579150 0.84 GSR (0.49) GSROTCGNAI3GNAO1GNAI1
Arginine SCHEMBL1278143 0.84 GSR (0.49) GSROTCGNAI3GNAO1GNAI1
SCHEMBL11660913 0.84 GNAI3 (0.46) GSROTCGNAI3GNAO1GNAI1
SCHEMBL301607 0.84 GNAI3 (0.46) GSROTCGNAI3GNAO1GNAI1
SCHEMBL2899157 0.84 OTC (0.43) GSROTCNOS2DDAH1NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10300167-B2 Functionalized calcium phosphate artificial bone and joint compositions and methods of use and manufacture Cabertech, Inc. (US) 2019-05-28 US claimed
EP-2739265-A1 FUNCTIONALIZED CALCIUM PHOSPHATE ARTIFICIAL BONE AND JOINT COMPOSITIONS AND METHODS OF USE AND MANUFACTURE Cabertech, Inc. (US) 2014-06-11 EP claimed
WO-2013016006-A1 FUNCTIONALIZED CALCIUM PHOSPHATE ARTIFICIAL BONE AND JOINT COMPOSITIONS AND METHODS OF USE AND MANUFACTURE Cabertech, Inc. (US) 2013-01-31 WO claimed
US-20120087950-A1 FUNCTIONALIZED CALCIUM PHOSPHATE ARTIFICIAL BONE AND JOINT COMPOSITIONS AND METHODS OF USE AND MANUFACTURE DUQUESNE UNIVERSITY OF THE HOLY SPIRIT 2012-04-12 US claimed
EP-2739265-B1 FUNCTIONALIZED CALCIUM PHOSPHATE ARTIFICIAL BONE AND JOINT COMPOSITIONS AND METHODS OF USE AND MANUFACTURE CABERTECH INC (US) 2020-08-26 EP disclosed
US-10300167-B2 Functionalized calcium phosphate artificial bone and joint compositions and methods of use and manufacture Cabertech, Inc. (US) 2019-05-28 US disclosed
EP-2739265-A1 FUNCTIONALIZED CALCIUM PHOSPHATE ARTIFICIAL BONE AND JOINT COMPOSITIONS AND METHODS OF USE AND MANUFACTURE Cabertech, Inc. (US) 2014-06-11 EP disclosed
WO-2013016006-A1 FUNCTIONALIZED CALCIUM PHOSPHATE ARTIFICIAL BONE AND JOINT COMPOSITIONS AND METHODS OF USE AND MANUFACTURE Cabertech, Inc. (US) 2013-01-31 WO disclosed
US-20120087950-A1 FUNCTIONALIZED CALCIUM PHOSPHATE ARTIFICIAL BONE AND JOINT COMPOSITIONS AND METHODS OF USE AND MANUFACTURE DUQUESNE UNIVERSITY OF THE HOLY SPIRIT 2012-04-12 US disclosed